Last reviewed · How we verify
Standards of Care
Standards of Care is a treatment approach that involves evidence-based practices and guidelines for managing various health conditions.
Standards of Care is a treatment approach that involves evidence-based practices and guidelines for managing various health conditions. Used for Management of various health conditions, including but not limited to diabetes, cardiovascular disease, and cancer.
At a glance
| Generic name | Standards of Care |
|---|---|
| Sponsor | Shahid Beheshti University of Medical Sciences |
| Modality | Small molecule |
| Therapeutic area | Multidisciplinary |
| Phase | FDA-approved |
Mechanism of action
Standards of Care are developed by medical organizations and experts to ensure that patients receive the best possible care for their specific condition. These standards are based on the latest research and clinical evidence, and are regularly updated to reflect new findings and best practices.
Approved indications
- Management of various health conditions, including but not limited to diabetes, cardiovascular disease, and cancer
Common side effects
- Variable
Key clinical trials
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) (PHASE2)
- Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (PHASE3)
- Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure) (NA)
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer (PHASE2)
- Shared Decision-Making Decision Aid for Newly Diagnosed Breast Cancer : A Multi-Center Randomized Controlled Trial (NA)
- Inhaled Ciclesonide Study in Preterm Infants (PHASE1)
- A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standards of Care CI brief — competitive landscape report
- Standards of Care updates RSS · CI watch RSS
- Shahid Beheshti University of Medical Sciences portfolio CI